Table 5 A comparison of the included and excluded cohorts. Using χ2 tests and Wilcoxon rank sum test p values are provided
|  | Included (n = 1354) | Excluded (n = 359) |  | ||||
|---|---|---|---|---|---|---|---|
Baseline characteristic | N (%) | Median | IQR (1st, 3rd quartile) | N (%) | Median | IQR (1st, 3rd quartile) | p value |
Age (years) | Â | 31.6 | 24.1, 41.9 | Â | 29.8 | 24.2, 40.8 | 0.39 |
Body mass index (kg/m2) | Â | 18.5 | 16.9, 20.3 | Â | 18.2 | 16.3, 20.3 | 0.06 |
Sex | Â | Â | Â | Â | Â | Â | 0.32 |
 Male | 959(70.8%) |  |  | 244 (68%) |  |  |  |
 Female | 395 (29.2%) | 115 (32%) | |||||
Ethnicity | Â | Â | Â | Â | Â | Â | 1.0 |
 African | 924 (68.2%) |  |  | 245 (68.2%) |  |  |  |
 Asian | 430 (31.8%) | 114 (31.8%) | |||||
Diabetes | Â | Â | Â | Â | Â | Â | 0.30 |
 Yes | 69 (5%) |  |  | 13 (3.6%) |  |  |  |
 No | 1285 (95%) | 346 (96.4%) | |||||
HIV | Â | Â | Â | Â | Â | Â | 0.10 |
 Yes | 104 (7.7%) |  |  | 18 (5%) |  |  |  |
 No | 1250 (92.3%) | 341 (95%) | |||||
Albumin (g/L) | Â | 34 | 30, 38 | Â | 35 | 30, 39.3 | 0.19 |
Time to positivity (hours) |  | 117 | 89, 153 | (n = 79 with values) | 105 | 85.5, 140.5 | 0.10 |
Cavity | Â | Â | Â | Â | Â | Â | 1.0 |
 Yes | 1049 (77.5%) |  |  | 278 (77.4%) |  |  |  |
 No | 305 (22.5%) | 81 (22.6%) | |||||
Average area affected | Â | 18.13 | 11.3, 27.5 | Â | 21.88 | 11.9, 32.5 | 0.001 |